Over the past few years, gene editing and CRISPR technology has proven to be a powerful tool for editing the genome in the pursuit of a greater understanding of how genes and pathways are involved in human health and disease. Its potential use in the detection and validation of novel drug targets and as a therapeutic agent are also clear future prospects for the technology.
In this series of free webinars, find out all you need to know about the latest techniques, technologies, and tools, including the innovations in CRISPR that are advancing translational research and beyond.
Register now to hear the latest from gene editing experts, plus, check out a selection of our on-demand webinars below.
Identifying genome-wide targets of osmotic stress tolerance in E. coli using CRISPR-mediated forward engineering
Monday, September 13, at 15:00 BST / 16:00 CEST / 07:00 PDT / 10:00 EDT
Join Katherine Krouse, senior research associate at Inscripta, to learn more about investigating the response to osmotic pressure in E.coli using an automated CRISPR editing workflow. This webinar will reveal how to design experimental methods for studying the osmotic stress response in E. coli, including how to create genome-wide libraries of up to 25,000 edits in an automated, massively parallel workflow. Krouse will also present how to track diverging E. coli populations cultured in salt solutions, and how to identify enriched and depleted variants, including genes known to be involved in the osmotic stress response and previously unknown targets.
Monday, September 13, at 16:00 BST / 17:00 CEST / 08:00 PDT / 11:00 EDT
Join Jennifer Bennet, from Merck KGaA, who will present the new Sigma-Aldrich® PURedit™ CRISPR reagent, specifically suited for preclinical and translational research. This webinar will highlight the key requirements of CRISPR reagents for preclinical and translational research, and how they can be used in a variety of applications to provide enhanced specificity without sacrificing cutting activity.
Thursday, September 23, at 10:00 BST / 11:00 CEST / 02:00 PDT / 05:00 EDT
Join Dr. Katia Mattis, research scientist at iotaSciences, to learn more about using genome engineering workflows to precisely edit the DNA sequence of cells and how to derive clonal genome-edited cultures using novel culture methods. This webinar will introduce critical parameters for successful genome engineering with an emphasis on single-cell cloning on hiPSCs. Mattis will also highlight how CRISPR/Cas9 genome editing and subcloning workflows benefit from automation, and common pitfalls in traditional single-cell cloning methods.
Discover more free on-demand gene editing and CRISPR webinars here:
Register for the Gene Editing and CRISPR Webinar Series here>>